Filing Flows › International Stem Cell (ISCO) › R&D spending
International Stem Cell (ISCO) R&D spending by quarter
International Stem Cell's R&D spending was $155K in Q2 2026 (second quarter 2026), -0.6% from Q1 2026. Over the last 7 quarters it ranged from $155K (Q2 2026) to $210K (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $155K | -0.6% | -4% |
| Q1 2026 | $156K | -12% | -17% |
| Q4 2025 | $177K | +12% | -16% |
| Q3 2025 | $158K | -2% | — |
| Q2 2025 | $162K | -13% | — |
| Q1 2025 | $187K | -11% | — |
| Q4 2024 | $210K | — | — |
Q2 2026 at a glance
International Stem Cell, Q2 2026: revenue $2.7M (+9% year over year), operating margin -1.3%, net loss $71K, operating cash flow $167K. The chart follows the revenue to costs, profit and cash.
Questions
What is International Stem Cell's R&D spending?
International Stem Cell's R&D spending was $155K in Q2 2026 (second quarter 2026), -0.6% from Q1 2026.
How has International Stem Cell's R&D spending changed?
Over the last 7 quarters it ranged from $155K (Q2 2026) to $210K (Q4 2024).
Q2 2026 results → · How International Stem Cell makes money →